Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 ,inter alia, to consider and approve Audited Financial Results for the ....
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anuh Pharma has called a Board Meeting on 23rd May, 2025 with a packed agenda. The main items are approval of audited financial results for Q4 and full year ended 31st March, 2025, and a recommendation on dividend for FY25. The Board will also consider a proposal to issue bonus shares, subject to shareholder and other approvals. Additionally, it will re-appoint Joint Managing Directors Ritesh Shah and Vivek Shah, re-appoint two directors retiring by rotation, and appoint a new Secretarial Auditor for a five-year term (FY26 to FY30). The trading window for insiders is closed from 1st April until 25th May, 2025, i.e., 48 hours after results are declared.
Investors should watch for the Q4/FY25 results and the bonus share proposal on 23rd May, as bonus issues typically lift retail interest and can lead to a short-term price adjustment. Dividend, if declared, will add to near-term return expectations.